Drug Shortage Report for METHYLDOPA
Report ID | 186504 |
Drug Identification Number | 00426830 |
Brand name | METHYLDOPA |
Common or Proper name | Methyldopa |
Company Name | AA PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | METHYLDOPA |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | C02AB |
ATC description | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2023-03-09 |
Actual start date | |
Estimated end date | 2023-04-24 |
Actual end date | 2023-04-24 |
Shortage status | Resolved |
Updated date | 2023-05-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-05-01 | French | Compare |
v6 | 2023-05-01 | English | Compare |
v5 | 2023-03-22 | French | Compare |
v4 | 2023-03-22 | English | Compare |
v3 | 2023-03-10 | English | Compare |
v2 | 2023-03-08 | French | Compare |
v1 | 2023-03-08 | English | Compare |
Showing 1 to 7 of 7